Skip to main content

Want a detailed portfolio tracker?

Neuraxis (NRXS) P/E (2023 - 2026)

Neuraxis (NRXS) P/E from Aug 9, 2023 to Jul 21, 2026. The TTM Neuraxis (NRXS) P/E is -10.01. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Neuraxis (NRXS)

YearP/EChange
2026-10.01+90.19%
2025-5.26+170.59%
2024-1.95+184.57%
2023-0.68N/A

Comparison Neuraxis (NRXS) P/E with competitors

Neuraxis (NRXS) P/E is -10.01.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.75%
FGENFibroGen Inc0.24-102.40%
CHRSCoherus Biosciences Inc0.85-108.47%
FBIOFortress Biotech Inc0.95-109.48%
ORMPOramed Pharmaceuticals Inc1.50-115.01%
AGENAgenus Inc3.01-130.06%
INVAInnoviva Inc3.15-131.50%
VXRTVaxart Inc3.55-135.45%
CRMDCorMedix Inc3.63-136.24%
CVACCureVac N.V.4.45-144.40%
GLPGGalapagos NV4.86-148.52%
SRPTSarepta Therapeutics Inc4.88-148.76%
ABEOAbeona Therapeutics Inc5.39-153.80%
ABUSArbutus Biopharma Corp5.60-155.88%
ZVRAZevra Therapeutics Inc5.89-158.79%
SPROSpero Therapeutics Inc6.23-162.20%
CGENCompugen Ltd6.31-163.06%
RIGLRigel Pharmaceuticals6.87-168.63%
SLXNSilexion Therapeutics Corp7.30-172.86%
OMEROmeros Corporation9.26-192.46%
AUPHAurinia Pharmaceuticals Inc9.58-195.72%
PLXProtalix BioTherapeutics Inc10.89-208.76%
ACADAcadia Pharmaceuticals Inc11.73-217.13%
TBPHTheravance Biopharma Inc12.26-222.46%
ADMAAdma Biologics Inc12.42-224.02%
HRMYHarmony Biosciences Holdings Inc13.82-238.02%
SABSSAB Biotherapeutics Inc14.14-241.17%
NAGENiagen Bioscience Inc14.82-247.98%
INCYIncyte Corp15.82-258.02%
REGNRegeneron Pharmaceuticals Inc15.86-258.36%
PBYIPuma Biotechnology Inc17.32-272.93%
CPRXCatalyst Pharmaceuticals Inc17.44-274.16%
EXELExelixis Inc17.54-275.15%
TGTXTG Therapeutics Inc18.97-289.41%
MDXGMimedx Group Inc20.55-305.25%
XOMAXOMA Royalty Corp22.87-328.45%
ARGXArgen X SE24.30-342.66%
CTMXCytomX Therapeutics Inc24.82-347.89%
XOMAOXOMA Royalty Corp25.34-353.12%
HALOHalozyme Therapeutics Inc25.62-355.90%
XOMAPXOMA Royalty Corp25.67-356.37%
VRTXVertex Pharmaceuticals Inc27.99-379.58%
RPRXRoyalty Pharma plc - Class A28.69-386.50%
SLNOSoleno Therapeutics Inc29.02-389.78%
ASNDAscendis Pharma A/S30.09-400.46%
LGNDLigand Pharmaceuticals Inc - Class B37.91-478.63%
APLSApellis Pharmaceuticals Inc39.02-489.70%
BMRNBiomarin Pharmaceutical Inc42.21-521.57%
KRYSKrystal Biotech Inc45.34-552.84%
ONCBeiGene Ltd69.54-794.50%
PHARPharming Group N.V.75.03-849.28%
TECHBio-Techne Corp101.96-1118.26%
VCELVericel Corp109.92-1197.78%
ALNYAlnylam Pharmaceuticals Inc117.96-1278.11%
GMABGenmab140.29-1501.08%
TLXTelix Pharmaceuticals Ltd162.15-1719.42%
CORTCorcept Therapeutics Inc212.86-2225.80%